Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MS-20 + Pembrolizumab in Advanced NSCLC
NCT04909034Phase 2Completed
- Sponsor
- Microbio Co., Ltd.
- Start
- Aug 2021
- Primary completion
- Oct 2024
- Modality
- Complex Communities
- Countries
- 1
01
Overview
A Phase 2 trial of MicrSoy-20 in non-small cell lung cancer (NSCLC), sponsored by Microbio Co., Ltd.. Started Aug 2021; status: completed.
02
Drugs
MicrSoy-20
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04909034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04909034.